レンチウイルスベクターの世界市場レポート 2024年

レンチウイルスベクター市場規模は、今後数年で急成長が見込まれます。2028年にはCAGR15.4％で255億米ドルに成長します。予測される成長の原動力は、個別化医療の拡大、遺伝子編集の革新、希少疾患治療の需要、レンチウイルスベクターの採用、ゲノム医療への資金提供、製造の拡張性重視です。主な動向としては、研究開発の拡大、CAR-T細胞療法への統合、次世代ベクターの開発、ワクチン開発への採用、生産技術の進歩などが挙げられます。

レンチウイルスベクター市場は、世界の慢性疾患の有病率の増加により、大きな成長が見込まれています。慢性疾患は、時間の経過とともにゆっくりと進行する長期的な病状を特徴とし、高齢化、不健康なライフスタイル、都市化、環境の影響などの要因により増加傾向にあります。レンチウイルスベクターは、増加する慢性疾患の負担に対処するためのワクチンや治療戦略を開発し、それによって患者の転帰を改善するための、多用途で効率的なツールとして登場しました。例えば、国立医学図書館が発表した報告書では、慢性疾患に罹患する人の数が大幅に増加し、2020年の7,152万2,000人から2050年には約1億4,266万人へと99.5％増加すると予測されています。この増加は、慢性疾患と闘い、エスカレートするヘルスケア需要を満たすためにレンチウイルスベクターが重要な役割を果たすことを強調しています。

レンチウイルスベクター市場の主要プレーヤーは、細胞ベースの免疫腫瘍学治療のためのレンチウイルスベクター製造の効率性と堅牢性を高めるために、LVベクター製造プラットフォームの進歩に力を注いでいます。そのような革新的なプラットフォームの一つがLentiSureであり、細胞ベースの免疫腫瘍学治療用のレンチウイルスベクターの製造を最適化するように設計されています。2023年5月にYposkesi sk pharmtecoによって発表されたLentiSureは、細胞・遺伝子治療におけるスケーラブルで信頼性の高いウイルスベクター製造技術に対する需要の高まりに対応し、レンチウイルス製造の弾力性と効率性を強化することを目的としています。LentiSureは、安定した製品品質や高い生産性といった特徴を持ち、慢性疾患に関連するアンメット・メディカル・ニーズに対応する細胞ベースの免疫腫瘍学的療法の開発と商業化を加速させることが期待されます。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

• 高インフレが市場に与える影響
• ウクライナ・ロシア戦争が市場に与える影響
• COVID-19による市場への影響

第5章 世界の市場規模と成長

• 世界のレンチウイルスベクター市場：促進要因と抑制要因
  • 市場促進要因
  • 市場抑制要因
• 世界のレンチウイルスベクター市場の実績：規模と成長, 2018-2023
• 世界のレンチウイルスベクター市場の予測：規模と成長, 2023-2028, 2033F

第6章 市場セグメンテーション

• 世界のレンチウイルスベクター市場：製品タイプ別、実績と予測, 2018-2023, 2023-2028F, 2033F
• キット
• 試薬および消耗品
• 世界のレンチウイルスベクター市場：適応症別、実績と予測, 2018-2023, 2023-2028F, 2033F
• がん
• 遺伝性疾患
• 感染症
• 獣医疾患
• その他の適応症
• 世界のレンチウイルスベクター市場：エンドユーザー別、実績と予測, 2018-2023, 2023-2028F, 2033F
• バイオテクノロジー企業
• 製薬会社
• 受託研究機関（CRO）
• 学術・研究機関

第7章 地域別・国別分析

• 世界のレンチウイルスベクター市場：地域別、実績と予測, 2018-2023, 2023-2028F, 2033F
• 世界のレンチウイルスベクター市場：国別、実績と予測, 2018-2023, 2023-2028F, 2033F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• レンチウイルスベクター市場：競合情勢
• レンチウイルスベクター市場：企業プロファイル
  • Pfizer Inc.
  • AbbVie Inc.
  • Bayer AG
  • Sanofi SA
  • Bristol Myers Squibb Company

第31章 その他の大手企業と革新的企業

• Thermo Fisher Scientific Inc.
• AstraZeneca plc
• Novartis AG
• GlaxoSmithKline plc（GSK）
• Eli Lilly and Company
• Agilent Technologies Inc.
• Amgen Inc.
• Merck KGaA
• Lonza Group Ag
• Cytiva
• Charles River Laboratories
• Bio-Rad Laboratories Inc.
• Promega Corporation
• Takara Bio Inc.
• Sino Biological Inc.

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の見通しと潜在的な分析

第36章 付録

A lentiviral vector is a viral vector derived from lentiviruses, a subgroup of retroviruses known for their ability to integrate genetic material into the DNA of host cells. These vectors are widely used in molecular biology and gene therapy applications to deliver genetic material into target cells for purposes such as gene expression, gene silencing, or genetic modification.

Key products in the lentiviral vector category include kits, reagents, and consumables. Lentiviral vector kits provide a comprehensive set of tools and components necessary for generating and manipulating lentiviral vectors. These kits find application across various indications such as cancer, genetic disorders, infectious diseases, veterinary diseases, and more. Users of lentiviral vector products include biotechnology companies, pharmaceutical companies, contract research organizations (CROs), as well as academic and research institutes.

The lentiviral vector market research report is one of a series of new reports from The Business Research Company that provides lentiviral vector market statistics, including lentiviral vector industry global market size, regional shares, competitors with a lentiviral vector market share, detailed lentiviral vector market segments, market trends and opportunities, and any further data you may need to thrive in the lentiviral vector industry. This lentiviral vector market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The lentiviral vector market size has grown rapidly in recent years. It will grow from $12.50 billion in 2023 to $14.37 billion in 2024 at a compound annual growth rate (CAGR) of 15.0%. The growth observed in the historic period can largely be attributed to several factors, including the prevalence of genetic disorders driving demand for gene delivery solutions, expansions within the biotech and pharmaceutical industries, increased investment in clinical trials for gene therapy, and regulatory approvals facilitating advancements in gene therapy technologies.

The lentiviral vector market size is expected to see rapid growth in the next few years. It will grow to $25.50 billion in 2028 at a compound annual growth rate (CAGR) of 15.4%. Forecasted growth is driven by personalized medicine expansion, gene editing innovations, rare disease therapy demand, lentiviral vector adoption, genomic medicine funding, and manufacturing scalability focus. Major trends include research and development expansion, integration in CAR-T cell therapy, next-generation vector development, adoption in vaccine development, and production technology advancements.

The lentiviral vectors market is poised for significant growth, driven by the increasing prevalence of chronic diseases worldwide. Chronic diseases, characterized by long-term medical conditions that progress slowly over time, are on the rise due to factors such as aging populations, unhealthy lifestyles, urbanization, and environmental influences. Lentiviral vectors have emerged as versatile and efficient tools for developing vaccines and treatment strategies to address the growing burden of chronic diseases, thereby improving patient outcomes. For example, a report published by the National Library of Medicine projected a substantial increase in the number of individuals affected by chronic illnesses, with an estimated 99.5% rise from 71.522 million in 2020 to around 142.66 million by 2050. This escalation underscores the critical role of lentiviral vectors in combating chronic diseases and meeting the escalating healthcare demands.

Key players in the lentiviral vectors market are concentrating their efforts on advancing LV vector production platforms to enhance the efficiency and robustness of lentivirus vector manufacturing for cell-based immuno-oncology therapies. One such innovative platform is LentiSure, designed to optimize the production of lentiviral vectors for cell-based immuno-oncology therapies. Launched by Yposkesi sk pharmteco in May 2023, LentiSure aims to bolster the resilience and efficiency of lentivirus production, catering to the escalating demand for scalable and reliable viral vector manufacturing technologies in cell and gene therapies. With features such as consistent product quality and high productivity, LentiSure offers promise in accelerating the development and commercialization of cell-based immuno-oncology therapies, addressing the unmet medical needs associated with chronic diseases.

In June 2021, Charles River Laboratories, a US-based pharmaceutical company, completed the acquisition of Vigene Biosciences for $292.5 million. This strategic acquisition was aimed at bolstering Charles River's gene therapy capabilities, particularly in the rapidly expanding cell and gene therapy contract development and manufacturing organization (CDMO) sectors for viral vectors and plasmid DNA. Vigene Biosciences, a US-based provider of viral vector-based gene delivery services and products, aligned with Charles River's strategic objectives, strengthening its position in the dynamic landscape of gene therapy and lentiviral vectors.

Major companies operating in the lentiviral vector market are Pfizer Inc., AbbVie Inc., Bayer AG, Sanofi SA, Bristol Myers Squibb Company, Thermo Fisher Scientific Inc., AstraZeneca plc, Novartis AG, GlaxoSmithKline plc (GSK), Eli Lilly and Company, Agilent Technologies Inc., Amgen Inc., Merck KGaA, Lonza Group Ag, Cytiva, Charles River Laboratories, Bio-Rad Laboratories Inc., Promega Corporation, Takara Bio Inc., Sino Biological Inc., OriGene Technologies Inc., Applied Biological Materials Inc., Oxford Biomedica, Sirion-Biotech GmbH, Yposkesi

North America was the largest region in the lentiviral vector market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the lentiviral vector market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the lentiviral vector market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The lentiviral vector market consists of sales of 3rd generation lentiviral vectors, Lenti-ORF clones, and lentiviral particles. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

• Including: 1) By Product Type: Kits; Reagents And Consumables
• 2) By Indication: Cancer; Genetic Disorder; Infectious Disease; Veterinary Disease
• 3) By End User: Biotechnology Companies; Pharmaceutical Companies; Contract Research Organization (CRO); Academic And Research Institutes
• Covering: Pfizer Inc.; AbbVie Inc.; Bayer AG; Sanofi SA; Bristol Myers Squibb Company

Table of Contents

1. Executive Summary

2. Lentiviral Vector Market Characteristics

3. Lentiviral Vector Market Trends And Strategies

4. Lentiviral Vector Market - Macro Economic Scenario

• 4.1. Impact Of High Inflation On The Market
• 4.2. Ukraine-Russia War Impact On The Market
• 4.3. COVID-19 Impact On The Market

5. Global Lentiviral Vector Market Size and Growth

• 5.1. Global Lentiviral Vector Market Drivers and Restraints
  • 5.1.1. Drivers Of The Market
  • 5.1.2. Restraints Of The Market
• 5.2. Global Lentiviral Vector Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
• 5.3. Global Lentiviral Vector Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Lentiviral Vector Market Segmentation

• 6.1. Global Lentiviral Vector Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Kits
• Reagents And Consumables
• 6.2. Global Lentiviral Vector Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Cancer
• Genetic Disorder
• Infectious Disease
• Veterinary Disease
• Other Indications
• 6.3. Global Lentiviral Vector Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Biotechnology Companies
• Pharmaceutical Companies
• Contract Research Organization (CRO)
• Academic And Research Institutes

7. Lentiviral Vector Market Regional And Country Analysis

• 7.1. Global Lentiviral Vector Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 7.2. Global Lentiviral Vector Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Lentiviral Vector Market

• 8.1. Asia-Pacific Lentiviral Vector Market Overview
• Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Lentiviral Vector Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.3. Asia-Pacific Lentiviral Vector Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.4. Asia-Pacific Lentiviral Vector Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Lentiviral Vector Market

• 9.1. China Lentiviral Vector Market Overview
• 9.2. China Lentiviral Vector Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.3. China Lentiviral Vector Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.4. China Lentiviral Vector Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Lentiviral Vector Market

• 10.1. India Lentiviral Vector Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.2. India Lentiviral Vector Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.3. India Lentiviral Vector Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Lentiviral Vector Market

• 11.1. Japan Lentiviral Vector Market Overview
• 11.2. Japan Lentiviral Vector Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.3. Japan Lentiviral Vector Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.4. Japan Lentiviral Vector Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Lentiviral Vector Market

• 12.1. Australia Lentiviral Vector Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.2. Australia Lentiviral Vector Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.3. Australia Lentiviral Vector Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Lentiviral Vector Market

• 13.1. Indonesia Lentiviral Vector Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.2. Indonesia Lentiviral Vector Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.3. Indonesia Lentiviral Vector Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Lentiviral Vector Market

• 14.1. South Korea Lentiviral Vector Market Overview
• 14.2. South Korea Lentiviral Vector Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.3. South Korea Lentiviral Vector Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.4. South Korea Lentiviral Vector Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Lentiviral Vector Market

• 15.1. Western Europe Lentiviral Vector Market Overview
• 15.2. Western Europe Lentiviral Vector Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.3. Western Europe Lentiviral Vector Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.4. Western Europe Lentiviral Vector Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Lentiviral Vector Market

• 16.1. UK Lentiviral Vector Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.2. UK Lentiviral Vector Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.3. UK Lentiviral Vector Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Lentiviral Vector Market

• 17.1. Germany Lentiviral Vector Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.2. Germany Lentiviral Vector Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.3. Germany Lentiviral Vector Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Lentiviral Vector Market

• 18.1. France Lentiviral Vector Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.2. France Lentiviral Vector Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.3. France Lentiviral Vector Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Lentiviral Vector Market

• 19.1. Italy Lentiviral Vector Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.2. Italy Lentiviral Vector Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.3. Italy Lentiviral Vector Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Lentiviral Vector Market

• 20.1. Spain Lentiviral Vector Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.2. Spain Lentiviral Vector Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.3. Spain Lentiviral Vector Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Lentiviral Vector Market

• 21.1. Eastern Europe Lentiviral Vector Market Overview
• 21.2. Eastern Europe Lentiviral Vector Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.3. Eastern Europe Lentiviral Vector Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.4. Eastern Europe Lentiviral Vector Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Lentiviral Vector Market

• 22.1. Russia Lentiviral Vector Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.2. Russia Lentiviral Vector Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.3. Russia Lentiviral Vector Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Lentiviral Vector Market

• 23.1. North America Lentiviral Vector Market Overview
• 23.2. North America Lentiviral Vector Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.3. North America Lentiviral Vector Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.4. North America Lentiviral Vector Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Lentiviral Vector Market

• 24.1. USA Lentiviral Vector Market Overview
• 24.2. USA Lentiviral Vector Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.3. USA Lentiviral Vector Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.4. USA Lentiviral Vector Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Lentiviral Vector Market

• 25.1. Canada Lentiviral Vector Market Overview
• 25.2. Canada Lentiviral Vector Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.3. Canada Lentiviral Vector Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.4. Canada Lentiviral Vector Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Lentiviral Vector Market

• 26.1. South America Lentiviral Vector Market Overview
• 26.2. South America Lentiviral Vector Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.3. South America Lentiviral Vector Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.4. South America Lentiviral Vector Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Lentiviral Vector Market

• 27.1. Brazil Lentiviral Vector Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.2. Brazil Lentiviral Vector Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.3. Brazil Lentiviral Vector Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Lentiviral Vector Market

• 28.1. Middle East Lentiviral Vector Market Overview
• 28.2. Middle East Lentiviral Vector Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.3. Middle East Lentiviral Vector Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.4. Middle East Lentiviral Vector Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Lentiviral Vector Market

• 29.1. Africa Lentiviral Vector Market Overview
• 29.2. Africa Lentiviral Vector Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.3. Africa Lentiviral Vector Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.4. Africa Lentiviral Vector Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Lentiviral Vector Market Competitive Landscape And Company Profiles

• 30.1. Lentiviral Vector Market Competitive Landscape
• 30.2. Lentiviral Vector Market Company Profiles
  • 30.2.1. Pfizer Inc.
    • 30.2.1.1. Overview
    • 30.2.1.2. Products and Services
    • 30.2.1.3. Strategy
    • 30.2.1.4. Financial Performance
  • 30.2.2. AbbVie Inc.
    • 30.2.2.1. Overview
    • 30.2.2.2. Products and Services
    • 30.2.2.3. Strategy
    • 30.2.2.4. Financial Performance
  • 30.2.3. Bayer AG
    • 30.2.3.1. Overview
    • 30.2.3.2. Products and Services
    • 30.2.3.3. Strategy
    • 30.2.3.4. Financial Performance
  • 30.2.4. Sanofi SA
    • 30.2.4.1. Overview
    • 30.2.4.2. Products and Services
    • 30.2.4.3. Strategy
    • 30.2.4.4. Financial Performance
  • 30.2.5. Bristol Myers Squibb Company
    • 30.2.5.1. Overview
    • 30.2.5.2. Products and Services
    • 30.2.5.3. Strategy
    • 30.2.5.4. Financial Performance

31. Lentiviral Vector Market Other Major And Innovative Companies

• 31.1. Thermo Fisher Scientific Inc.
• 31.2. AstraZeneca plc
• 31.3. Novartis AG
• 31.4. GlaxoSmithKline plc (GSK)
• 31.5. Eli Lilly and Company
• 31.6. Agilent Technologies Inc.
• 31.7. Amgen Inc.
• 31.8. Merck KGaA
• 31.9. Lonza Group Ag
• 31.10. Cytiva
• 31.11. Charles River Laboratories
• 31.12. Bio-Rad Laboratories Inc.
• 31.13. Promega Corporation
• 31.14. Takara Bio Inc.
• 31.15. Sino Biological Inc.

32. Global Lentiviral Vector Market Competitive Benchmarking

33. Global Lentiviral Vector Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Lentiviral Vector Market

35. Lentiviral Vector Market Future Outlook and Potential Analysis

• 35.1 Lentiviral Vector Market In 2028 - Countries Offering Most New Opportunities
• 35.2 Lentiviral Vector Market In 2028 - Segments Offering Most New Opportunities
• 35.3 Lentiviral Vector Market In 2028 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer